Vital Record https://vitalrecord.tamu.edu/xml-feed/ibt/ A news publication of Texas A&M Health, Vital Record offers insight on the latest in health, medicine and scientific discovery from experts across our five colleges and numerous centers and institutes. Tue, 17 Jun 2025 20:35:41 +0000 en-US hourly 1 https://vitalrecord.tamu.edu/wp-content/uploads/2016/02/cropped-Screen-Shot-2016-02-03-at-2.37.26-PM.png Vital Record https://vitalrecord.tamu.edu/xml-feed/ibt/ 32 32 Gut health explained: What’s worth following and what’s just hype? https://vitalrecord.tamu.edu/gut-health-explained-whats-worth-following-and-whats-just-hype/ Tue, 03 Jun 2025 15:53:54 +0000 https://vitalrecord.tamu.edu/gut-health-explained-whats-worth-following-and-whats-just-hype/ older adult woman eats yogurt while standing in front of softly sunny windows

Improving gut health has gained popularity on social media, with influencers recommending everything from diet changes to supplements. Although trends may be tempting, it’s important to understand the differences between gimmicks and evidence-based advice. Gut health is often overlooked when our…

]]> Texas A&M Health awarded $11.7 million in CPRIT funding to advance cancer research and prevention https://vitalrecord.tamu.edu/texas-am-health-awarded-11-7-million-in-cprit-funding-to-advance-cancer-research-and-prevention/ Thu, 22 May 2025 16:01:11 +0000 https://vitalrecord.tamu.edu/texas-am-health-awarded-11-7-million-in-cprit-funding-to-advance-cancer-research-and-prevention/ closeup of researcher piping liquid into a dish

The Texas A&M University Health Science Center (Texas A&M Health) has received $11.7 million in new funding from the Cancer Prevention and Research Institute of Texas (CPRIT) to support innovative cancer research, prevention and recruitment initiatives. The funding was part of CPRIT’s latest round…

]]> Two Texas A&M Health faculty named 2025 University Distinguished Professors https://vitalrecord.tamu.edu/two-texas-am-health-faculty-named-2025-university-distinguished-professors/ Fri, 21 Feb 2025 20:34:54 +0000 https://vitalrecord.tamu.edu/two-texas-am-health-faculty-named-2025-university-distinguished-professors/ Kenneth Ramos and William Sage

Texas A&M University has announced the 2025 University Distinguished Professors, the highest achievement a faculty member can earn at the university. Among them are two faculty members from the Texas A&M Health Science Center (Texas A&M Health), Kenneth Ramos, PhD, and William Sage, MD, JD. The…

]]> Thought leaders gather to find a path to more inclusive, effective clinical trials https://vitalrecord.tamu.edu/thought-leaders-gather-to-find-a-path-to-more-inclusive-effective-clinical-trials/ Wed, 07 Aug 2024 20:04:56 +0000 https://vitalrecord.tamu.edu/thought-leaders-gather-to-find-a-path-to-more-inclusive-effective-clinical-trials/ Panel discussion at the Finding Solution to Barriers in Clinical Trials conference hosted by Texas A&M Health. From left: Joseph B. McCormick, MD; Joy Alonzo, PharmD; Jamie Fergie, MD; Mary Dale Peterson, MD; and moderator Kenneth Ramos, MD.

The Texas A&M Health conference, “Finding Solutions to Barriers in Clinical Trials,” held on July 19, 2024, at TMC3 in Houston, Texas, served as a platform for addressing ongoing challenges in human clinical research studies. This day-long event brought together a diverse group of stakeholders,…

]]> Texas A&M Health, partner institutions awarded $4 million from National Institutes of Health to create multi-institutional commercialization hub https://vitalrecord.tamu.edu/texas-am-health-partner-institutions-awarded-4-million-from-national-institutes-of-health-to-create-multi-institutional-commercialization-hub/ Wed, 06 Dec 2023 15:57:31 +0000 https://vitalrecord.tamu.edu/texas-am-health-partner-institutions-awarded-4-million-from-national-institutes-of-health-to-create-multi-institutional-commercialization-hub/ scientists working in a laboratory look at a Petri dish together

Texas A&M University Health Science Center (Texas A&M Health), the Gulf Coast Consortia (GCC) and their partner institutions, Texas Southern University (TSU), University of Texas Medical Branch, and TMC Innovation, have been awarded a four-year, $4 million cooperative research agreement (U01) grant…

]]> Opening of TMC3 Collaborative Building marks launch of Helix Park, a 37-acre campus fostering innovation in health care and life science https://vitalrecord.tamu.edu/opening-of-tmc3-collaborative-building-marks-launch-of-helix-park-a-37-acre-campus-fostering-innovation-in-health-care-and-life-science/ Fri, 27 Oct 2023 13:37:58 +0000 https://vitalrecord.tamu.edu/opening-of-tmc3-collaborative-building-marks-launch-of-helix-park-a-37-acre-campus-fostering-innovation-in-health-care-and-life-science/ TMC3 Grand Opening Celebration at Helix Park in Houston

Texas Medical Center (TMC), The University of Texas MD Anderson Cancer Center, Texas A&M University Health Science Center (Texas A&M Health), and The University of Texas Health Science Center at Houston (UTHealth Houston) today celebrated the opening of the TMC3 Collaborative Building and the…

]]> Texas A&M Health researchers solve the mystery behind antibiotic-resistant C. difficile infection https://vitalrecord.tamu.edu/texas-am-health-researchers-solve-the-mystery-behind-antibiotic-resistant-c-difficile-infection/ Wed, 25 Oct 2023 13:14:09 +0000 https://vitalrecord.tamu.edu/texas-am-health-researchers-solve-the-mystery-behind-antibiotic-resistant-c-difficile-infection/ Julian Hurdle, C. diff infection researcher, stands in a lab

Researchers at Texas A&M University Health Science Center (Texas A&M Health) have uncovered why C. diff (also known as Clostridioides difficile or C. difficile) infection has developed resistance to the antibiotic metronidazole. C. diff is a bacterium that infects the colon and causes diarrhea and…

]]> Nano-size carbon material could be used to treat Down syndrome https://vitalrecord.tamu.edu/nano-size-carbon-material-could-be-used-to-treat-down-syndrome/ Thu, 13 Jul 2023 16:27:48 +0000 https://vitalrecord.tamu.edu/nano-size-carbon-material-could-be-used-to-treat-down-syndrome/ 3D rendering of hydrogen sulfide

Scientists at the Texas A&M University Health Science Center (Texas A&M Health) have discovered that a nano-sized carbon material derived from the oxidation of carbon-rich sources could be used to treat Down syndrome and other disorders associated with high levels of hydrogen sulfide. Hydrogen…

]]> Inaugural symposium paves way for future cancer research https://vitalrecord.tamu.edu/inaugural-symposium-paves-way-for-future-cancer-research/ Tue, 27 Jun 2023 15:07:37 +0000 https://vitalrecord.tamu.edu/inaugural-symposium-paves-way-for-future-cancer-research/ Chapkin Lab members posing

The Texas A&M Health Center of Excellence in Cancer Research hosted its first cancer research symposium in College Station, Texas, on May 22, 2023. The event brought together cancer researchers from across the region to meet, learn from each other and build momentum toward their shared goal of…

]]> Texas A&M Health awarded $3 million from National Cancer Institute https://vitalrecord.tamu.edu/texas-am-health-awarded-3-million-from-national-cancer-institute/ Mon, 05 Jun 2023 14:00:06 +0000 https://vitalrecord.tamu.edu/texas-am-health-awarded-3-million-from-national-cancer-institute/ researcher works with liquid samples in a laboratory

Texas A&M University Health Science Center (Texas A&M Health) has been awarded a new five-year $3 million grant from the National Cancer Institute to study immune-based treatments for early precancerous lesions in the gastrointestinal tract. Roderick Dashwood, PhD, FRSB, director of the Center for…

]]> Colorectal cancer and COVID-19: Inhibitors to combat both https://vitalrecord.tamu.edu/colorectal-cancer-and-covid-19-inhibitors-to-combat-both/ Wed, 10 May 2023 13:21:42 +0000 https://vitalrecord.tamu.edu/colorectal-cancer-and-covid-19-inhibitors-to-combat-both/ 3D illustration of colon cancer closeup

A new study from the Texas A&M Health Institute of Biosciences and Technology suggests that drugs called bromodomain and extraterminal domain (BET) inhibitors could help reduce the risk of colorectal cancer and COVID-19. The study found that colon cancer cells have more of a protein called ACE2,…

]]> Texas A&M receives $6 million to create Center of Excellence in Cancer Research https://vitalrecord.tamu.edu/texas-am-receives-6-million-to-create-center-of-excellence-in-cancer/ Tue, 04 Apr 2023 15:00:46 +0000 https://vitalrecord.tamu.edu/texas-am-receives-6-million-to-create-center-of-excellence-in-cancer/ scientists works in a lab

Texas A&M University Health Science Center (Texas A&M Health) has been awarded a five-year, $6 million grant from the Cancer Prevention and Research Institute of Texas, CPRIT, to support the creation of a Texas Regional Excellence in Cancer, or TREC, Center. The grant takes advantage of resources…

]]>